,Set,NGenes,Direction,PValue,FDR
1,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,2.07684899217947e-07,0.000171340041854806
2,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,7.42222884872709e-07,0.000306166940009992
3,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,4.37522464751569e-06,0.00120318677806681
4,WP_COMPLEMENT_ACTIVATION,11,Up,4.96130567012121e-05,0.010232692944625
5,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,0.000324907005396277,0.0536096558903857
6,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.000904310265649933,0.124342661526866
7,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,128,Up,0.00129789438571317,0.150458673340925
8,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.00162540351484505,0.150458673340925
9,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Up,0.00164136734553736,0.150458673340925
10,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.00206855635100303,0.17065589895775
11,WP_SELENIUM_MICRONUTRIENT_NETWORK,50,Up,0.00317364591191444,0.238023443393583
12,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Up,0.00490095738213929,0.30814906365842
13,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,11,Down,0.00543492082613395,0.30814906365842
14,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,0.00552311092698882,0.30814906365842
15,WP_FERROPTOSIS,48,Up,0.00583476567283856,0.30814906365842
16,WP_COMPLEMENT_SYSTEM,53,Up,0.00597622426489057,0.30814906365842
17,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.0076977917082704,0.341991409414342
18,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.00822691248746948,0.341991409414342
19,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Up,0.00946062577165608,0.341991409414342
20,WP_G1_TO_S_CELL_CYCLE_CONTROL,49,Up,0.00953395413937092,0.341991409414342
21,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.0096261264403114,0.341991409414342
22,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.00963970870843861,0.341991409414342
23,WP_TP53_NETWORK,14,Up,0.00989297292496148,0.341991409414342
24,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.00994884100114448,0.341991409414342
25,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,63,Up,0.0103875696978048,0.342789800027559
26,WP_ATR_SIGNALING,10,Up,0.0134988324483007,0.428328337301848
27,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Up,0.0157968819142296,0.482682502934793
28,WP_DNA_MISMATCH_REPAIR,21,Up,0.0167690790096354,0.49408893510533
29,WP_SMALL_LIGAND_GPCRS,7,Down,0.0175732918467841,0.499929854261962
30,WP_ALLOGRAFT_REJECTION,50,Up,0.0186024061983951,0.511566170455865
31,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.0223993380237356,0.565945146716395
32,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.0231506031555335,0.565945146716395
33,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.0231506031555335,0.565945146716395
34,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Down,0.0238794717246489,0.565945146716395
35,WP_DOPAMINE_METABOLISM,7,Up,0.0241731559735258,0.565945146716395
36,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Up,0.0246957882203518,0.565945146716395
37,WP_RETT_SYNDROME,30,Down,0.0258714915272273,0.576864338107096
38,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.0270675461784916,0.581018046409178
39,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.0298132962175642,0.581018046409178
40,WP_ID_SIGNALING,11,Up,0.0300947065319025,0.581018046409178
41,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.0311183452952616,0.581018046409178
42,WP_FOXA2_PATHWAY,9,Up,0.0312375659038058,0.581018046409178
43,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Down,0.0317469915119139,0.581018046409178
44,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.0333072096722928,0.581018046409178
45,WP_DNA_DAMAGE_RESPONSE,57,Up,0.0334231937406665,0.581018046409178
46,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Down,0.0334903116186319,0.581018046409178
47,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.033906504257203,0.581018046409178
48,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,16,Down,0.0342194411852116,0.581018046409178
49,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Down,0.0345089506352118,0.581018046409178
50,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,33,Down,0.0367798738670286,0.606867918805971
51,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Up,0.0433089809034042,0.700586455790362
52,WP_NUCLEAR_RECEPTORS_METAPATHWAY,176,Up,0.0447160971102969,0.709438079153749
53,WP_ESTROGEN_METABOLISM_WP697,6,Up,0.0469849060157573,0.709533197552544
54,WP_ETHER_LIPID_BIOSYNTHESIS,15,Down,0.046992779196386,0.709533197552544
55,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.0474588448697368,0.709533197552544
56,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.0483972083017501,0.709533197552544
57,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.050794126773454,0.709533197552544
58,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Down,0.0513368713540035,0.709533197552544
59,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Up,0.0517837778178547,0.709533197552544
60,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.0519270779225844,0.709533197552544
61,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,20,Up,0.0531495107877994,0.709533197552544
62,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,26,Down,0.053322494846373,0.709533197552544
63,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.0579489985627434,0.745273256161452
64,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Up,0.0603303939843761,0.745273256161452
65,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.0604035348675674,0.745273256161452
66,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.0613507660558944,0.745273256161452
67,WP_COMPLEMENT_AND_COAGULATION_CASCADES,25,Up,0.061428583538156,0.745273256161452
68,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,25,Up,0.061428583538156,0.745273256161452
69,WP_GASTRIC_CANCER_NETWORK_1,16,Down,0.0627819467489018,0.74857032074973
70,WP_PPARALPHA_PATHWAY,16,Up,0.0642073108793264,0.74857032074973
71,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.0649906858741185,0.74857032074973
72,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.0655955715270185,0.74857032074973
73,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.0662371314117943,0.74857032074973
74,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.0680423433424497,0.758580179155689
75,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Up,0.0713524776193834,0.774741355735674
76,WP_SPINA_BIFIDA,10,Down,0.0713701127708014,0.774741355735674
77,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,28,Up,0.0730354333068058,0.776059743873668
78,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.073372921238965,0.776059743873668
79,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Up,0.0752802555797768,0.784343676353318
80,WP_ESTROGEN_RECEPTOR_PATHWAY,9,Up,0.0762731296637888,0.784343676353318
81,WP_SILDENAFIL_TREATMENT,11,Up,0.0775261273069692,0.784343676353318
82,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Up,0.0784007126560196,0.784343676353318
83,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.0812741562022841,0.784343676353318
84,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,51,Down,0.0815129180133346,0.784343676353318
85,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.0816997078709203,0.784343676353318
86,WP_MEVALONATE_PATHWAY,7,Down,0.0817618862622853,0.784343676353318
87,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Up,0.0829219242474424,0.786328592001609
88,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.0842552501275231,0.789892969945529
89,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,8,Down,0.0857234276457377,0.79462727873858
90,WP_ANGIOGENESIS,14,Up,0.087313125780556,0.795536548337274
91,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.0882964435918812,0.795536548337274
92,WP_PPAR_SIGNALING,37,Up,0.0894426396361629,0.795536548337274
93,WP_DNA_REPLICATION,34,Up,0.0908031985819868,0.795536548337274
94,WP_CELL_CYCLE,88,Up,0.0914503756812005,0.795536548337274
95,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.0924452865901978,0.795536548337274
96,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Up,0.0938305564279961,0.795536548337274
97,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.0944792511791428,0.795536548337274
98,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.0954520702109565,0.795536548337274
99,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,2,Up,0.0954643858004728,0.795536548337274
100,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.0990648722886875,0.817285196381672
101,WP_SERINE_METABOLISM,7,Down,0.100194172472855,0.818417745446585
102,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Down,0.101266657566158,0.819068553843927
103,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Down,0.102502024250862,0.821011359290883
104,WP_PRION_DISEASE_PATHWAY,29,Down,0.107065901709684,0.841825410032337
105,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.108160048112091,0.841825410032337
106,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.1081618102587,0.841825410032337
107,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.109422395588424,0.84367734916308
108,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Up,0.110637363391488,0.8451465259072
109,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.114789650550366,0.868820749578458
110,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.116777050060728,0.875827875455459
111,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.118009559499814,0.877098077363485
112,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.119386176207232,0.879407101526487
113,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Up,0.121730847628543,0.886276184082946
114,WP_ATM_SIGNALING,33,Up,0.12348985634211,0.886276184082946
115,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.123726036934523,0.886276184082946
116,WP_SULINDAC_METABOLIC_PATHWAY,3,Up,0.127891563220424,0.886276184082946
117,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.127895105361458,0.886276184082946
118,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Up,0.128304342957307,0.886276184082946
119,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.129114888801283,0.886276184082946
120,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.129509149178413,0.886276184082946
121,WP_PURINE_METABOLISM,10,Up,0.132187596131699,0.886276184082946
122,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.135788307176506,0.886276184082946
123,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.137358542106143,0.886276184082946
124,WP_BENZOAPYRENE_METABOLISM,4,Up,0.137736575618564,0.886276184082946
125,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.138247239491254,0.886276184082946
126,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.138755928276845,0.886276184082946
127,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.139695714856385,0.886276184082946
128,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.139800081070566,0.886276184082946
129,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,8,Down,0.141323170270082,0.886276184082946
130,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.142153962414088,0.886276184082946
131,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.142485746329543,0.886276184082946
132,WP_IRON_METABOLISM_IN_PLACENTA,9,Up,0.142991128229941,0.886276184082946
133,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,20,Up,0.144700153938468,0.886276184082946
134,WP_SLEEP_REGULATION,10,Up,0.145668819134427,0.886276184082946
135,WP_ONCOSTATIN_M_SIGNALING,56,Up,0.146136513665597,0.886276184082946
136,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.148114105214431,0.886276184082946
137,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Up,0.148829396764617,0.886276184082946
138,WP_MONOAMINE_GPCRS,3,Down,0.150821053379324,0.886276184082946
139,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.150985614299912,0.886276184082946
140,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.153131228407348,0.886276184082946
141,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Up,0.154155363156979,0.886276184082946
142,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.155444485242464,0.886276184082946
143,WP_LUNG_FIBROSIS,35,Down,0.157303526263563,0.886276184082946
144,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Down,0.158300356745854,0.886276184082946
145,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Down,0.159652142282729,0.886276184082946
146,WP_ALSTROM_SYNDROME,27,Up,0.160636760885534,0.886276184082946
147,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Up,0.160687303960698,0.886276184082946
148,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.161468528943363,0.886276184082946
149,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.161498517173284,0.886276184082946
150,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Down,0.163744136531947,0.886276184082946
151,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Up,0.166443537621174,0.886276184082946
152,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.166578951780645,0.886276184082946
153,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.172574825893093,0.886276184082946
154,WP_GALANIN_RECEPTOR_PATHWAY,11,Up,0.17424958057981,0.886276184082946
155,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.174395488880308,0.886276184082946
156,WP_PHOSPHOINOSITIDES_METABOLISM,37,Down,0.174701256176003,0.886276184082946
157,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,164,Up,0.175351080388413,0.886276184082946
158,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Up,0.175537166303631,0.886276184082946
159,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.177379248211687,0.886276184082946
160,WP_TRANSSULFURATION_PATHWAY,8,Down,0.178481931428359,0.886276184082946
161,WP_VITAMIN_D_RECEPTOR_PATHWAY,84,Up,0.178705208950461,0.886276184082946
162,WP_AGERAGE_PATHWAY,55,Up,0.179111793089406,0.886276184082946
163,WP_IRON_METABOLISM_DISORDERS,12,Up,0.180168513668439,0.886276184082946
164,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Down,0.181322314910374,0.886276184082946
165,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.181422032644416,0.886276184082946
166,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Up,0.183608970972058,0.886276184082946
167,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.186764772428749,0.886276184082946
168,WP_SPINAL_CORD_INJURY,65,Up,0.188029300161439,0.886276184082946
169,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.188036613983731,0.886276184082946
170,WP_NRF2ARE_REGULATION,21,Up,0.188465256237047,0.886276184082946
171,WP_UROTENSINIIMEDIATED_SIGNALING,49,Up,0.188834069078394,0.886276184082946
172,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.188866606232434,0.886276184082946
173,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.189858825669841,0.886276184082946
174,WP_TAMOXIFEN_METABOLISM,3,Up,0.19035345447027,0.886276184082946
175,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,76,Up,0.190443194440094,0.886276184082946
176,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.190512255264744,0.886276184082946
177,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.192709137769468,0.886276184082946
178,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,8,Up,0.193101928978865,0.886276184082946
179,WP_PROTEASOME_DEGRADATION,57,Up,0.193351428091332,0.886276184082946
180,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Up,0.194072574346313,0.886276184082946
181,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Up,0.194443623416986,0.886276184082946
182,WP_PURINERGIC_SIGNALING,16,Down,0.195965143778125,0.888303536356887
183,WP_AUTOPHAGY,27,Up,0.199567750050181,0.890051572856833
184,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Up,0.199626107731378,0.890051572856833
185,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.200449033288298,0.890051572856833
186,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.207544707193386,0.890051572856833
187,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,9,Up,0.208194859135478,0.890051572856833
188,WP_CELLULAR_PROTEOSTASIS,6,Up,0.211040647613544,0.890051572856833
189,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Up,0.211381976925202,0.890051572856833
190,WP_PRIMARY_OVARIAN_INSUFFICIENCY,87,Up,0.211475540614213,0.890051572856833
191,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,23,Down,0.2139641699629,0.890051572856833
192,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Up,0.215498652548463,0.890051572856833
193,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.215940460485003,0.890051572856833
194,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.216116263394727,0.890051572856833
195,WP_NRF2_PATHWAY,69,Up,0.218380392143001,0.890051572856833
196,WP_PTF1A_RELATED_REGULATORY_PATHWAY,5,Down,0.21925608981521,0.890051572856833
197,WP_ENERGY_METABOLISM,41,Down,0.2194426033072,0.890051572856833
198,WP_RETINOBLASTOMA_GENE_IN_CANCER,66,Up,0.220204448628068,0.890051572856833
199,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Up,0.221602022280884,0.890051572856833
200,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Down,0.222062921031665,0.890051572856833
201,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.222104741536513,0.890051572856833
202,WP_KREBS_CYCLE_DISORDERS,11,Down,0.222767348472807,0.890051572856833
203,WP_BLADDER_CANCER,30,Up,0.22374209936311,0.890051572856833
204,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.224091756815971,0.890051572856833
205,WP_JOUBERT_SYNDROME,66,Down,0.224953192995965,0.890051572856833
206,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Up,0.225350161281534,0.890051572856833
207,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Down,0.226568369519514,0.890051572856833
208,WP_NAD_METABOLISM,11,Up,0.227538751752235,0.890051572856833
209,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Down,0.230659468131129,0.890051572856833
210,WP_INTEGRATED_CANCER_PATHWAY,38,Up,0.230776483575781,0.890051572856833
211,WP_P38_MAPK_SIGNALING,31,Up,0.232697357759156,0.890051572856833
212,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,15,Down,0.238985300733025,0.890051572856833
213,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,62,Down,0.239892138725303,0.890051572856833
214,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.240584614861816,0.890051572856833
215,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.241206082383697,0.890051572856833
216,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Up,0.24237002202995,0.890051572856833
217,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Down,0.244457446959099,0.890051572856833
218,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.245548608307992,0.890051572856833
219,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,26,Up,0.245776108668937,0.890051572856833
220,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.245982499849717,0.890051572856833
221,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,82,Up,0.246396481368611,0.890051572856833
222,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.246950236364212,0.890051572856833
223,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.247242981931465,0.890051572856833
224,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.247580019962374,0.890051572856833
225,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,11,Down,0.249710928206536,0.890051572856833
226,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Up,0.250955787111507,0.890051572856833
227,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.253082282327196,0.890051572856833
228,WP_OSTEOCLAST_SIGNALING,9,Up,0.253504883962635,0.890051572856833
229,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,9,Up,0.253774763425282,0.890051572856833
230,WP_ENDOTHELIN_PATHWAYS,12,Down,0.254113576053542,0.890051572856833
231,WP_NEPHROGENESIS,3,Up,0.254764573776521,0.890051572856833
232,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Up,0.258187078740141,0.890051572856833
233,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Down,0.258234869004123,0.890051572856833
234,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Down,0.258726372711122,0.890051572856833
235,WP_NEURAL_CREST_DIFFERENTIATION,35,Down,0.25912325239095,0.890051572856833
236,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.262798974571695,0.890051572856833
237,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Up,0.263093036053696,0.890051572856833
238,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.264617917411716,0.890051572856833
239,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.265122164921923,0.890051572856833
240,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.265175738597503,0.890051572856833
241,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.271401614646588,0.890051572856833
242,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.272193255819434,0.890051572856833
243,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.274104607907304,0.890051572856833
244,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.274365535518617,0.890051572856833
245,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Down,0.274786752430389,0.890051572856833
246,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.275472534834209,0.890051572856833
247,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Up,0.278680468796994,0.890051572856833
248,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.279146906244516,0.890051572856833
249,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.279168040940837,0.890051572856833
250,WP_5Q35_COPY_NUMBER_VARIATION,75,Up,0.279233309118831,0.890051572856833
251,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.280281731937253,0.890051572856833
252,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,75,Down,0.280764157884709,0.890051572856833
253,WP_HIPPO_SIGNALING_REGULATION,41,Down,0.280802644375582,0.890051572856833
254,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Up,0.280908659647678,0.890051572856833
255,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.281281676829747,0.890051572856833
256,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.281624395222187,0.890051572856833
257,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Up,0.283306692846875,0.890051572856833
258,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.284440516443518,0.890051572856833
259,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,27,Up,0.285077673200775,0.890051572856833
260,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.285689912734656,0.890051572856833
261,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Up,0.285810845995609,0.890051572856833
262,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.286060927214047,0.890051572856833
263,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.286139666213688,0.890051572856833
264,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.287954750573314,0.890051572856833
265,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,47,Down,0.287973460552536,0.890051572856833
266,WP_IL19_SIGNALING,20,Up,0.288686622172863,0.890051572856833
267,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,8,Down,0.290257725650114,0.890051572856833
268,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.291556774269078,0.890051572856833
269,WP_APOPTOSIS,69,Up,0.294052816636667,0.890051572856833
270,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.294091118199896,0.890051572856833
271,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.294510433833467,0.890051572856833
272,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.294992954078465,0.890051572856833
273,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.295942670883806,0.890051572856833
274,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.296804310075073,0.890051572856833
275,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.297546772284912,0.890051572856833
276,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,58,Up,0.297762708010286,0.890051572856833
277,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,39,Up,0.300480713030486,0.893389790997479
278,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.30193371178459,0.893389790997479
279,WP_PDGF_PATHWAY,36,Up,0.302617342421163,0.893389790997479
280,WP_ESTROGEN_SIGNALING,21,Up,0.305622357473834,0.893389790997479
281,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.307631902217,0.893389790997479
282,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.308025986410438,0.893389790997479
283,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Down,0.308590740729298,0.893389790997479
284,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,11,Down,0.309440171752419,0.893389790997479
285,WP_AXON_GUIDANCE,33,Up,0.309708847620723,0.893389790997479
286,WP_MEASLES_VIRUS_INFECTION,99,Down,0.31155228906385,0.893389790997479
287,WP_NUCLEOTIDE_GPCRS,7,Down,0.311906268494552,0.893389790997479
288,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,29,Down,0.313070560492944,0.893389790997479
289,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.314052248969814,0.893389790997479
290,WP_IL6_SIGNALING,39,Up,0.314864518433424,0.893389790997479
291,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.315122944460929,0.893389790997479
292,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Up,0.317912392507564,0.894195661650133
293,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.319557472108757,0.894195661650133
294,WP_DISORDERS_IN_KETOLYSIS,3,Down,0.320775728521702,0.894195661650133
295,WP_FOLATE_METABOLISM,36,Up,0.321415333357815,0.894195661650133
296,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.321836759102042,0.894195661650133
297,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.324369210766542,0.894195661650133
298,WP_MESODERMAL_COMMITMENT_PATHWAY,74,Down,0.32540639167938,0.894195661650133
299,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,1,Down,0.327575160757286,0.894195661650133
300,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,47,Down,0.328882869492951,0.894195661650133
301,WP_GLYOXYLATE_METABOLISM,5,Up,0.329581887936171,0.894195661650133
302,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,64,Up,0.330335149279902,0.894195661650133
303,WP_IL5_SIGNALING,37,Down,0.330781856018771,0.894195661650133
304,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Up,0.330952336579049,0.894195661650133
305,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,51,Down,0.332456735703689,0.894195661650133
306,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Up,0.332946386268354,0.894195661650133
307,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.334041187639158,0.894195661650133
308,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.33636432921308,0.894195661650133
309,WP_HEME_BIOSYNTHESIS,8,Up,0.33636432921308,0.894195661650133
310,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.336996173510677,0.894195661650133
311,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,56,Up,0.337420353674094,0.894195661650133
312,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Down,0.338622772679088,0.894195661650133
313,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Up,0.339381790668078,0.894195661650133
314,WP_IL7_SIGNALING,24,Up,0.34266109812829,0.894195661650133
315,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Down,0.343821447724644,0.894195661650133
316,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,9,Up,0.343959625346467,0.894195661650133
317,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.345577485331476,0.894195661650133
318,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.346002398399068,0.894195661650133
319,WP_ASPIRIN_AND_MIRNAS,8,Up,0.348604791157979,0.894195661650133
320,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,112,Up,0.348817640602637,0.894195661650133
321,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.349093361147908,0.894195661650133
322,WP_FOCAL_ADHESION,117,Down,0.350565956566175,0.894195661650133
323,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Up,0.350695817015444,0.894195661650133
324,WP_KLEEFSTRA_SYNDROME,25,Down,0.351605952652755,0.894195661650133
325,WP_RAC1PAK1P38MMP2_PATHWAY,52,Up,0.352258897013689,0.894195661650133
326,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Down,0.355098300288793,0.898638336620411
327,WP_INSULIN_SIGNALING,127,Up,0.357303911976997,0.898810346002423
328,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.357345204228842,0.898810346002423
329,WP_ERBB_SIGNALING,68,Up,0.358651837955353,0.899354912805977
330,WP_ADIPOGENESIS,80,Up,0.360832794108236,0.900391556966371
331,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.362185694775551,0.900391556966371
332,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Up,0.362339390197376,0.900391556966371
333,WP_ONECARBON_METABOLISM,22,Down,0.364653409145377,0.902754711732648
334,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.365478877234793,0.902754711732648
335,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,50,Down,0.367329004606151,0.904616205373356
336,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.370115989597978,0.904864826032938
337,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,16,Down,0.370929561473479,0.904864826032938
338,WP_CIRCADIAN_RHYTHM_GENES,113,Up,0.371157564187954,0.904864826032938
339,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,11,Up,0.374915315857317,0.904864826032938
340,WP_OXIDATION_BY_CYTOCHROME_P450,16,Up,0.375643780417035,0.904864826032938
341,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,0.377048527152217,0.904864826032938
342,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.377327839830671,0.904864826032938
343,WP_TYPE_II_DIABETES_MELLITUS,12,Up,0.379731040322791,0.904864826032938
344,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Up,0.382056840633977,0.904864826032938
345,WP_REGULATION_OF_ACTIN_CYTOSKELETON,88,Down,0.383930754699306,0.904864826032938
346,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.384648176056394,0.904864826032938
347,WP_BLOOD_CLOTTING_CASCADE,6,Down,0.385209831377134,0.904864826032938
348,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Down,0.386477817474828,0.904864826032938
349,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Down,0.386998665549679,0.904864826032938
350,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.388334499712479,0.904864826032938
351,WP_GLUTATHIONE_METABOLISM,10,Up,0.388572569915224,0.904864826032938
352,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,4,Up,0.389174317852673,0.904864826032938
353,WP_ECTODERM_DIFFERENTIATION,72,Down,0.390344892359583,0.904864826032938
354,WP_TYPE_II_INTERFERON_SIGNALING,31,Down,0.391063298218868,0.904864826032938
355,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.394304957303988,0.904864826032938
356,WP_POSTCOVID_NEUROINFLAMMATION,13,Down,0.395354149418979,0.904864826032938
357,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Up,0.397201000848239,0.904864826032938
358,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.398025223837134,0.904864826032938
359,WP_TNFALPHA_SIGNALING,81,Up,0.398188058803499,0.904864826032938
360,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.39870312856883,0.904864826032938
361,WP_NOTCH_SIGNALING_WP61,49,Down,0.400008807452021,0.904864826032938
362,WP_10Q22Q23_COPY_NUMBER_VARIATION,25,Down,0.400710953566801,0.904864826032938
363,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.401395008935477,0.904864826032938
364,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.403094574508786,0.904864826032938
365,WP_SYNAPTIC_VESICLE_PATHWAY,20,Down,0.403795811062048,0.904864826032938
366,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Up,0.403810900486628,0.904864826032938
367,WP_15Q25_COPY_NUMBER_VARIATION,27,Up,0.404339637139643,0.904864826032938
368,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Up,0.405158577514751,0.904864826032938
369,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.407852060638406,0.904864826032938
370,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.407852060638406,0.904864826032938
371,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,36,Down,0.409253194575207,0.904864826032938
372,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Down,0.409702741502832,0.904864826032938
373,WP_IL4_SIGNALING,50,Up,0.412244126014788,0.904864826032938
374,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.412627370136249,0.904864826032938
375,WP_ULCERATIVE_COLITIS_SIGNALING,13,Up,0.412836330716039,0.904864826032938
376,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.413768088346805,0.904864826032938
377,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,18,Down,0.414597073186979,0.904864826032938
378,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.416860393765677,0.904864826032938
379,WP_IL26_SIGNALING,33,Up,0.417910539841268,0.904864826032938
380,WP_IDO_METABOLIC_PATHWAY,6,Down,0.41907188719558,0.904864826032938
381,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,77,Up,0.421308758860328,0.904864826032938
382,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.421637527345724,0.904864826032938
383,WP_ARYLAMINE_METABOLISM,1,Up,0.423072025354802,0.904864826032938
384,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.423234605990205,0.904864826032938
385,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.42597339357714,0.904864826032938
386,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.427907319126367,0.904864826032938
387,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.428549224332401,0.904864826032938
388,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.429249160182303,0.904864826032938
389,WP_CHEMOKINE_SIGNALING,115,Down,0.43071624893299,0.904864826032938
390,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,24,Up,0.43185356765054,0.904864826032938
391,WP_ENDODERM_DIFFERENTIATION,82,Down,0.432164595891065,0.904864826032938
392,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.43286046641854,0.904864826032938
393,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Up,0.433102748619571,0.904864826032938
394,WP_CILIARY_LANDSCAPE,182,Up,0.433659543035302,0.904864826032938
395,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.433898767884349,0.904864826032938
396,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.43433511649581,0.904864826032938
397,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Up,0.435466897479987,0.904937507357656
398,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.437582922106003,0.905371930991336
399,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.437870788443083,0.905371930991336
400,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Down,0.439954598492753,0.907406359391303
401,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Down,0.444434373437419,0.912996549269627
402,WP_PYRIMIDINE_METABOLISM,70,Up,0.445084691186044,0.912996549269627
403,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Up,0.445984981037163,0.912996549269627
404,WP_TGFB_SMAD_SIGNALING,6,Down,0.447193771983285,0.913182738922475
405,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Up,0.448364488216081,0.913182738922475
406,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Down,0.450574299065027,0.913182738922475
407,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.45456779306653,0.913182738922475
408,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.456027605116952,0.913182738922475
409,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Down,0.457344568954388,0.913182738922475
410,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Up,0.458313586268912,0.913182738922475
411,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,13,Up,0.45946225164595,0.913182738922475
412,WP_SMALL_CELL_LUNG_CANCER,64,Up,0.459932543194816,0.913182738922475
413,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,20,Down,0.460259666190175,0.913182738922475
414,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.460777936182234,0.913182738922475
415,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,270,Up,0.462206776234704,0.913182738922475
416,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.464242698016336,0.913182738922475
417,WP_GLIOBLASTOMA_SIGNALING,65,Up,0.464922960265603,0.913182738922475
418,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Down,0.467284379501945,0.913182738922475
419,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.473078858810534,0.913182738922475
420,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.474193317581905,0.913182738922475
421,WP_KALLMANN_SYNDROME,11,Up,0.476115037172889,0.913182738922475
422,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.476269905179061,0.913182738922475
423,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Down,0.47680391204603,0.913182738922475
424,WP_THERMOGENESIS,74,Down,0.47770831867724,0.913182738922475
425,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Up,0.47844002177218,0.913182738922475
426,WP_NOTCH_SIGNALING_WP268,34,Down,0.480239390169257,0.913182738922475
427,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.481088781256743,0.913182738922475
428,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Down,0.481780851713916,0.913182738922475
429,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.482360446609361,0.913182738922475
430,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.482995293222591,0.913182738922475
431,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.483358498277293,0.913182738922475
432,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.484009781215109,0.913182738922475
433,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.487463743116723,0.913182738922475
434,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Up,0.48904394264299,0.913182738922475
435,WP_PARKINSONS_DISEASE_PATHWAY,25,Up,0.489606202464258,0.913182738922475
436,WP_ACE_INHIBITOR_PATHWAY,4,Up,0.491286254853171,0.913182738922475
437,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.492198887673236,0.913182738922475
438,WP_LUNG_PATHOLOGY_OF_COVID19,16,Up,0.492470471896966,0.913182738922475
439,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.495588576370975,0.913182738922475
440,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Up,0.496641355936122,0.913182738922475
441,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.49771791818101,0.913182738922475
442,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.498406226266358,0.913182738922475
443,WP_GLUCURONIDATION,7,Up,0.498464393693671,0.913182738922475
444,WP_NEUROINFLAMMATION,10,Up,0.499171899015168,0.913182738922475
445,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Down,0.500069794461515,0.913182738922475
446,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.500747728115272,0.913182738922475
447,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Up,0.504263071208888,0.913182738922475
448,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.505387020702619,0.913182738922475
449,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Up,0.509170665286796,0.913182738922475
450,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Up,0.509631514059143,0.913182738922475
451,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.510363474140078,0.913182738922475
452,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.510517795842251,0.913182738922475
453,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1,Down,0.512661160370682,0.913182738922475
454,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Down,0.513803199027491,0.913182738922475
455,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,40,Up,0.515350203556028,0.913182738922475
456,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.51711847815929,0.913182738922475
457,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Up,0.51792411581762,0.913182738922475
458,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.518273277593779,0.913182738922475
459,WP_INTERFERON_TYPE_I_SIGNALING,50,Up,0.518552286774262,0.913182738922475
460,WP_PEPTIDE_GPCRS,14,Down,0.520119830095663,0.913182738922475
461,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.520705912490737,0.913182738922475
462,WP_ACUTE_MYELOID_LEUKEMIA,56,Down,0.523318240150836,0.913182738922475
463,WP_SULFATASE_AND_AROMATASE_PATHWAY,3,Up,0.524963562898677,0.913182738922475
464,WP_CREATINE_PATHWAY,2,Down,0.527436052443944,0.913182738922475
465,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.527445633015941,0.913182738922475
466,WP_G13_SIGNALING,30,Down,0.527847173592957,0.913182738922475
467,WP_NEPHROTIC_SYNDROME,26,Down,0.529142716854162,0.913182738922475
468,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.529225241701701,0.913182738922475
469,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.529267231322296,0.913182738922475
470,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,18,Up,0.529938440254378,0.913182738922475
471,WP_PREIMPLANTATION_EMBRYO,20,Down,0.532204365664581,0.913182738922475
472,WP_CAMKK2_PATHWAY,29,Down,0.53276332622936,0.913182738922475
473,WP_HISTONE_MODIFICATIONS,35,Down,0.533167863190722,0.913182738922475
474,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.53527072098015,0.913182738922475
475,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.536020270040333,0.913182738922475
476,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.538181096354601,0.913182738922475
477,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,39,Up,0.54165092783521,0.913182738922475
478,WP_HIPPOYAP_SIGNALING,15,Down,0.543922849076514,0.913182738922475
479,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.544438026306093,0.913182738922475
480,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Up,0.544555044715367,0.913182738922475
481,WP_IL11_SIGNALING,40,Down,0.544558002163483,0.913182738922475
482,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.545936525589688,0.913182738922475
483,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,88,Up,0.546328793104534,0.913182738922475
484,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.54681401011381,0.913182738922475
485,WP_VITAMIN_B12_DISORDERS,9,Down,0.547508351809898,0.913182738922475
486,WP_CORI_CYCLE,11,Up,0.547836980404621,0.913182738922475
487,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,94,Up,0.548037730187997,0.913182738922475
488,WP_TAR_SYNDROME,45,Down,0.548353527641767,0.913182738922475
489,WP_IL18_SIGNALING,190,Up,0.550223176069456,0.913182738922475
490,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,11,Up,0.550696457445164,0.913182738922475
491,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,11,Up,0.55123437132819,0.913182738922475
492,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,23,Down,0.552538425580677,0.913182738922475
493,WP_SEROTONIN_AND_ANXIETY,6,Up,0.553811021111747,0.913182738922475
494,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.555642369406455,0.913182738922475
495,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.556027752920973,0.913182738922475
496,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Down,0.557033863537804,0.913182738922475
497,WP_TCELL_ACTIVATION_SARSCOV2,60,Up,0.557293038298143,0.913182738922475
498,WP_GASTRIN_SIGNALING,91,Up,0.559905062122898,0.913182738922475
499,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.561626533582522,0.913182738922475
500,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,60,Up,0.5619515739251,0.913182738922475
501,WP_IRINOTECAN_PATHWAY,5,Down,0.562664348577057,0.913182738922475
502,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.564469014273783,0.913182738922475
503,WP_GLUCOCORTICOID_BIOSYNTHESIS,3,Up,0.564897700940724,0.913182738922475
504,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Down,0.56522224257262,0.913182738922475
505,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,19,Down,0.565905539777607,0.913182738922475
506,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Down,0.566859320892193,0.913182738922475
507,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.568684642966546,0.913182738922475
508,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.568985302130762,0.913182738922475
509,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.570214483111438,0.913182738922475
510,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.570309680389414,0.913182738922475
511,WP_IL1_SIGNALING,51,Down,0.571679129227983,0.913182738922475
512,WP_INTERFERONMEDIATED_SIGNALING,14,Up,0.572674480477741,0.913182738922475
513,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Up,0.572705831219837,0.913182738922475
514,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.573525529590807,0.913182738922475
515,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.575013039139892,0.913182738922475
516,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.57585137769633,0.913182738922475
517,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,60,Up,0.57588835877418,0.913182738922475
518,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Up,0.575945445100973,0.913182738922475
519,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.576271897160225,0.913182738922475
520,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.576582681874142,0.913182738922475
521,WP_IL3_SIGNALING,45,Down,0.576688735731648,0.913182738922475
522,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Down,0.579811142780471,0.913841100014986
523,WP_MRNA_PROCESSING,124,Up,0.579987485274267,0.913841100014986
524,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,9,Up,0.580427559282246,0.913841100014986
525,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Up,0.586513166232345,0.918650302182007
526,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.588079717437242,0.918650302182007
527,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,165,Up,0.588418032850361,0.918650302182007
528,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.589760793772666,0.918650302182007
529,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.591947947580798,0.918650302182007
530,WP_DOPAMINERGIC_NEUROGENESIS,5,Up,0.593644148590973,0.918650302182007
531,WP_VALPROIC_ACID_PATHWAY,8,Up,0.594073240968989,0.918650302182007
532,WP_RAS_SIGNALING,114,Up,0.594958999918033,0.918650302182007
533,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,35,Down,0.596776183043719,0.918650302182007
534,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Up,0.596797593195646,0.918650302182007
535,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.597777109635551,0.918650302182007
536,WP_CILIOPATHIES,116,Up,0.59789787676946,0.918650302182007
537,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.597957833056652,0.918650302182007
538,WP_OVARIAN_INFERTILITY,21,Up,0.599804378141124,0.919670662716814
539,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.600952456378762,0.919670662716814
540,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.601966251960096,0.919670662716814
541,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.60346519934143,0.920256542433788
542,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,33,Down,0.604804826657208,0.92059775275313
543,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.609170375105529,0.924061036384627
544,WP_PDGFRBETA_PATHWAY,27,Up,0.609584130650401,0.924061036384627
545,WP_ACETYLCHOLINE_SYNTHESIS,4,Up,0.611593137837726,0.924061036384627
546,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Down,0.612888405274837,0.924061036384627
547,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.615231830209749,0.924061036384627
548,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,20,Up,0.615936349752277,0.924061036384627
549,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Up,0.617511132790056,0.924061036384627
550,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.617840070409121,0.924061036384627
551,WP_MTHFR_DEFICIENCY,18,Up,0.619024969976469,0.924061036384627
552,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Up,0.621018456195762,0.924061036384627
553,WP_CHOLESTASIS,9,Up,0.621232535038658,0.924061036384627
554,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Up,0.625472834327896,0.924061036384627
555,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.626410879784773,0.924061036384627
556,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.626690141057704,0.924061036384627
557,WP_ALPHA_6_BETA_4_SIGNALING,24,Up,0.626707655740899,0.924061036384627
558,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.632033833273747,0.924061036384627
559,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Up,0.632193130972557,0.924061036384627
560,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.632617392805298,0.924061036384627
561,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.632784541987508,0.924061036384627
562,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.632977549552006,0.924061036384627
563,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.633170555096172,0.924061036384627
564,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.634179615923685,0.924061036384627
565,WP_OSTEOBLAST_SIGNALING,3,Down,0.636165799235745,0.924061036384627
566,WP_HYPERTROPHY_MODEL,13,Up,0.636220119130148,0.924061036384627
567,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Up,0.639521426637001,0.924061036384627
568,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.640275240844736,0.924061036384627
569,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.640696839385115,0.924061036384627
570,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Down,0.641633338393175,0.924061036384627
571,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Down,0.64177295622736,0.924061036384627
572,WP_CHOLESTEROL_METABOLISM,50,Up,0.642567597824591,0.924061036384627
573,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,26,Up,0.643421530259069,0.924061036384627
574,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Up,0.644228405925003,0.924061036384627
575,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Up,0.644430943186055,0.924061036384627
576,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,28,Up,0.645162614493994,0.924061036384627
577,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Up,0.649929105092463,0.926465063657845
578,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,22,Down,0.65009668478485,0.926465063657845
579,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.650210026494415,0.926465063657845
580,WP_TRANSLATION_FACTORS,49,Down,0.653721118916875,0.92859258868833
581,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.653954295791418,0.92859258868833
582,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Down,0.656818511529111,0.929843330396241
583,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.657089286813344,0.929843330396241
584,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Up,0.658281492826451,0.929935328051065
585,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Up,0.664694142564698,0.934511521445513
586,WP_NRXN1_DELETION_SYNDROME,2,Down,0.664717472143394,0.934511521445513
587,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,42,Down,0.670061097216954,0.934511521445513
588,WP_COPPER_HOMEOSTASIS,39,Up,0.670638158150447,0.934511521445513
589,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.672561476369683,0.934511521445513
590,WP_PROLACTIN_SIGNALING,70,Up,0.672729512195411,0.934511521445513
591,WP_EGFEGFR_SIGNALING,138,Down,0.673145809995138,0.934511521445513
592,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.673680035896552,0.934511521445513
593,WP_APOPTOSIS_MODULATION_AND_SIGNALING,73,Up,0.675003066148387,0.934511521445513
594,WP_LEPTIN_SIGNALING,70,Up,0.675487118848319,0.934511521445513
595,WP_CANCER_PATHWAYS,294,Up,0.679370298045093,0.934511521445513
596,WP_BENZENE_METABOLISM,3,Up,0.67972224749303,0.934511521445513
597,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.680288310171299,0.934511521445513
598,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.681164169089237,0.934511521445513
599,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.682156684128406,0.934511521445513
600,WP_FRAGILE_X_SYNDROME,83,Up,0.682666432872197,0.934511521445513
601,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.683139830235066,0.934511521445513
602,WP_VEGFAVEGFR2_SIGNALING,338,Down,0.684189220164874,0.934511521445513
603,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.684520208047829,0.934511521445513
604,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.685230097664492,0.934511521445513
605,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.685308449060043,0.934511521445513
606,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Up,0.688016737966779,0.936656450202299
607,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Down,0.69229135317872,0.940923173595459
608,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.696431878956625,0.943917430580237
609,WP_MACROPHAGE_MARKERS,8,Down,0.696782685119229,0.943917430580237
610,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Up,0.698451303548414,0.944023370480689
611,WP_LIPID_PARTICLES_COMPOSITION,5,Down,0.699149429531759,0.944023370480689
612,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.704025825095673,0.946537943718307
613,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Up,0.704225715770832,0.946537943718307
614,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Up,0.704684741030917,0.946537943718307
615,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.706149224373774,0.946537943718307
616,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Down,0.706748331309669,0.946537943718307
617,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Up,0.708772247573713,0.947710055507801
618,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.713622025666174,0.951723795007144
619,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Up,0.715789845768125,0.951723795007144
620,WP_MAPK_CASCADE,30,Up,0.716078090363008,0.951723795007144
621,WP_TYPE_III_INTERFERON_SIGNALING,6,Up,0.716934891421079,0.951723795007144
622,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.717568928340371,0.951723795007144
623,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.718727863997405,0.951723795007144
624,WP_PROSTAGLANDIN_SIGNALING,24,Down,0.719849270405404,0.951723795007144
625,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Up,0.723164937324298,0.953630369603264
626,WP_G_PROTEIN_SIGNALING,62,Down,0.72531874554291,0.953630369603264
627,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.731519971700794,0.953630369603264
628,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.73235882616576,0.953630369603264
629,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Up,0.732445202958627,0.953630369603264
630,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Up,0.732901885124431,0.953630369603264
631,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Up,0.732901885124431,0.953630369603264
632,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.735515758502226,0.953630369603264
633,WP_MATRIX_METALLOPROTEINASES,10,Down,0.739537451722982,0.953630369603264
634,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Up,0.740295234299059,0.953630369603264
635,WP_PLEURAL_MESOTHELIOMA,247,Up,0.74029752413363,0.953630369603264
636,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,135,Up,0.743268433239843,0.953630369603264
637,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.744184081205389,0.953630369603264
638,WP_OREXIN_RECEPTOR_PATHWAY,114,Down,0.746645882264814,0.953630369603264
639,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.747727328518901,0.953630369603264
640,WP_BDNFTRKB_SIGNALING,26,Down,0.74929554550269,0.953630369603264
641,WP_13Q1212_COPY_NUMBER_VARIATION,17,Down,0.751052314800446,0.953630369603264
642,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,26,Up,0.751515989975177,0.953630369603264
643,WP_CYTOSINE_METHYLATION,7,Down,0.751819626508458,0.953630369603264
644,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.754509695887205,0.953630369603264
645,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,1,Up,0.754800268088463,0.953630369603264
646,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Down,0.755375953399699,0.953630369603264
647,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Up,0.756643332631643,0.953630369603264
648,WP_IL2_SIGNALING,37,Down,0.757245764036652,0.953630369603264
649,WP_ENDOMETRIAL_CANCER,48,Up,0.757324241905344,0.953630369603264
650,WP_ZINC_HOMEOSTASIS,20,Down,0.759784177138546,0.953630369603264
651,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.759824867319844,0.953630369603264
652,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.759982161562634,0.953630369603264
653,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,27,Up,0.76069086277979,0.953630369603264
654,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.76115451690557,0.953630369603264
655,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.761516720056957,0.953630369603264
656,WP_MONOAMINE_TRANSPORT,11,Up,0.761960827067467,0.953630369603264
657,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.763630382023648,0.953630369603264
658,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Down,0.763769171590807,0.953630369603264
659,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,39,Up,0.766998310848998,0.953630369603264
660,WP_STEROID_BIOSYNTHESIS,2,Up,0.771170965717446,0.953630369603264
661,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Down,0.771517029274546,0.953630369603264
662,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,122,Down,0.772132248415588,0.953630369603264
663,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,49,Up,0.772919376648335,0.953630369603264
664,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.773375291081944,0.953630369603264
665,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Up,0.77481208838018,0.953630369603264
666,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Up,0.774900279658193,0.953630369603264
667,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,8,Up,0.776041337990174,0.953630369603264
668,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,14,Up,0.776217888528065,0.953630369603264
669,WP_RANKLRANK_SIGNALING,47,Up,0.776305956156939,0.953630369603264
670,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Up,0.777979440437899,0.953630369603264
671,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Down,0.778213127689625,0.953630369603264
672,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.778410730761085,0.953630369603264
673,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.779978467298577,0.953630369603264
674,WP_AMINO_ACID_METABOLISM,57,Down,0.780141058719677,0.953630369603264
675,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.784946930792563,0.953630369603264
676,WP_NONSMALL_CELL_LUNG_CANCER,58,Up,0.786698971957636,0.953630369603264
677,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.787117770665834,0.953630369603264
678,WP_MELANOMA,53,Up,0.788635267678775,0.953630369603264
679,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.790411535480388,0.953630369603264
680,WP_VITAMIN_A1_AND_A5X_PATHWAYS,4,Down,0.791439044960892,0.953630369603264
681,WP_TRYPTOPHAN_METABOLISM,17,Up,0.793187133185064,0.953630369603264
682,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Up,0.79345157918322,0.953630369603264
683,WP_BREAST_CANCER_PATHWAY,83,Up,0.797594279405637,0.953630369603264
684,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Down,0.797893894770092,0.953630369603264
685,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.798390432575082,0.953630369603264
686,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.800358903113987,0.953630369603264
687,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.801278453070448,0.953630369603264
688,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.801695620942629,0.953630369603264
689,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.802472283311479,0.953630369603264
690,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,81,Up,0.802978290670669,0.953630369603264
691,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Down,0.803861910083141,0.953630369603264
692,WP_IL9_SIGNALING,15,Down,0.804219113464305,0.953630369603264
693,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Down,0.805417881461251,0.953630369603264
694,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.805966660223097,0.953630369603264
695,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.805966660223097,0.953630369603264
696,WP_NUCLEAR_RECEPTORS,21,Down,0.806625714173906,0.953630369603264
697,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,41,Up,0.807405814634853,0.953630369603264
698,WP_UREA_CYCLE_AND_RELATED_DISEASES,4,Down,0.808168280795316,0.953630369603264
699,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Up,0.810047435667792,0.953630369603264
700,WP_BARDETBIEDL_SYNDROME,62,Down,0.81006181603125,0.953630369603264
701,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,36,Up,0.810296835262895,0.953630369603264
702,WP_TGFBETA_RECEPTOR_SIGNALING,34,Down,0.812225679129341,0.953829595563501
703,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Up,0.812778431128656,0.953829595563501
704,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Up,0.814007078549587,0.953885575867178
705,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,94,Down,0.815138583013771,0.953885575867178
706,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,11,Up,0.816648581191947,0.954075364337516
707,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Down,0.817613675862574,0.954075364337516
708,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.818828839926678,0.95414377533829
709,WP_BURN_WOUND_HEALING,62,Up,0.825370339237041,0.959454603070709
710,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Up,0.825712446279034,0.959454603070709
711,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.830140661101772,0.961859548288576
712,WP_METABOLIC_EPILEPTIC_DISORDERS,59,Up,0.83207264530968,0.961859548288576
713,WP_VITAMIN_D_METABOLISM,6,Up,0.832262745504342,0.961859548288576
714,WP_IL10_ANTIINFLAMMATORY_SIGNALING,11,Down,0.832445718155204,0.961859548288576
715,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,27,Up,0.834930431208624,0.963156394656818
716,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.836398673721881,0.963156394656818
717,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Down,0.837565037453165,0.963156394656818
718,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.839017776851892,0.963156394656818
719,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.841234516029351,0.963156394656818
720,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Up,0.842186356487545,0.963156394656818
721,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.842739204364415,0.963156394656818
722,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.842907778111785,0.963156394656818
723,WP_NETRINUNC5B_SIGNALING,35,Up,0.848644259166271,0.968370005272716
724,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.852962176806062,0.970819743585308
725,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Down,0.855111972802164,0.970819743585308
726,WP_KIT_RECEPTOR_SIGNALING,51,Down,0.85528011081439,0.970819743585308
727,WP_GPR40_PATHWAY,7,Up,0.855498125559416,0.970819743585308
728,WP_IL17_SIGNALING,24,Down,0.863162959286078,0.972024368036096
729,WP_ALZHEIMERS_DISEASE,183,Up,0.863464894295727,0.972024368036096
730,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,183,Up,0.863464894295727,0.972024368036096
731,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,16,Down,0.863565673742611,0.972024368036096
732,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.864215796489989,0.972024368036096
733,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.864509879249084,0.972024368036096
734,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Up,0.864921448874892,0.972024368036096
735,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,47,Up,0.866326084352764,0.972024368036096
736,WP_GPCRS_OTHER,13,Up,0.867163557423717,0.972024368036096
737,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.870440480388615,0.973004102245922
738,WP_HUNGER_AND_SATIETY,2,Up,0.871921070881394,0.973004102245922
739,WP_15Q11Q13_COPY_NUMBER_VARIATION,29,Up,0.872499652611671,0.973004102245922
740,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.872755194741797,0.973004102245922
741,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.879846977212979,0.974947775633435
742,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Down,0.881357529415452,0.974947775633435
743,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.881987283919384,0.974947775633435
744,WP_BASE_EXCISION_REPAIR,29,Up,0.882432325733707,0.974947775633435
745,WP_MIRNA_BIOGENESIS,6,Up,0.883520121961637,0.974947775633435
746,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.885440501621227,0.974947775633435
747,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.889012780409992,0.974947775633435
748,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,10,Down,0.890224323889525,0.974947775633435
749,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.890292138007646,0.974947775633435
750,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,6,Up,0.892467581841875,0.974947775633435
751,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.893313972954836,0.974947775633435
752,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.894969653175533,0.974947775633435
753,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.895146340000693,0.974947775633435
754,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.895512959657055,0.974947775633435
755,WP_PI3KAKT_SIGNALING,175,Up,0.896031664049836,0.974947775633435
756,WP_HEART_DEVELOPMENT,15,Up,0.896435719079247,0.974947775633435
757,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,27,Down,0.898584854565528,0.974947775633435
758,WP_ACUTE_VIRAL_MYOCARDITIS,66,Up,0.898817374559681,0.974947775633435
759,WP_GPCRS_CLASS_A_RHODOPSINLIKE,46,Up,0.89891867913476,0.974947775633435
760,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.898929039041834,0.974947775633435
761,WP_RETINOL_METABOLISM,5,Up,0.900165394836463,0.974947775633435
762,WP_WNT_SIGNALING_WP428,59,Down,0.9031318066715,0.974947775633435
763,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,25,Up,0.904813519989168,0.974947775633435
764,WP_SPHINGOLIPID_PATHWAY,21,Down,0.90537295388432,0.974947775633435
765,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.906038835178425,0.974947775633435
766,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.906377545142142,0.974947775633435
767,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.906405992619205,0.974947775633435
768,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,13,Down,0.908056372104211,0.97545118097132
769,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Down,0.910042164378734,0.976313115230762
770,WP_NEOVASCULARIZATION_PROCESSES,23,Up,0.912437760687111,0.976665193408583
771,WP_METHYLATION_PATHWAYS,5,Down,0.913373863335957,0.976665193408583
772,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.915672833875397,0.976665193408583
773,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Up,0.918999912703506,0.976665193408583
774,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.919293555418053,0.976665193408583
775,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.924401921497754,0.976665193408583
776,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Down,0.925594547485428,0.976665193408583
777,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Down,0.927708493214474,0.976665193408583
778,WP_TCA_CYCLE_IN_SENESCENCE,9,Up,0.928179898978229,0.976665193408583
779,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.928360725038465,0.976665193408583
780,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,6,Down,0.928769487635902,0.976665193408583
781,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.92915169100096,0.976665193408583
782,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.929418728079599,0.976665193408583
783,WP_WNT_SIGNALING_WP363,40,Down,0.930145827008359,0.976665193408583
784,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Down,0.930728517339009,0.976665193408583
785,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Up,0.930941655600728,0.976665193408583
786,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.931282582857082,0.976665193408583
787,WP_NPHP1_DELETION_SYNDROME,10,Down,0.932965951256766,0.976665193408583
788,WP_CCL18_SIGNALING,23,Down,0.93315962610349,0.976665193408583
789,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.936118188331565,0.976665193408583
790,WP_MINERALOCORTICOID_BIOSYNTHESIS,2,Up,0.936579164430778,0.976665193408583
791,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.937176388390096,0.976665193408583
792,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,13,Up,0.939112023606012,0.976665193408583
793,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,50,Down,0.939480163554506,0.976665193408583
794,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.941818877606019,0.976665193408583
795,WP_OSTEOPONTIN_SIGNALING,12,Up,0.943354108057624,0.976665193408583
796,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.943503474196594,0.976665193408583
797,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.943517768662595,0.976665193408583
798,WP_KININKALLIKREIN_PATHWAY,2,Down,0.944787169755199,0.976753652942405
799,WP_FOXP3_IN_COVID19,9,Up,0.946523950796068,0.977324479858267
800,WP_VITAMIN_B12_METABOLISM,24,Up,0.948074105277398,0.977701421067316
801,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Down,0.951515520537685,0.979564468434015
802,WP_INTEGRINMEDIATED_CELL_ADHESION,70,Up,0.952390430477572,0.979564468434015
803,WP_GASTRIC_CANCER_NETWORK_2,25,Down,0.956577026632264,0.979564468434015
804,WP_AEROBIC_GLYCOLYSIS,10,Up,0.956819390741706,0.979564468434015
805,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.956819390741706,0.979564468434015
806,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.95711058000146,0.979564468434015
807,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,25,Down,0.95838380495645,0.979564468434015
808,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Up,0.95937950362992,0.979564468434015
809,WP_HEPATITIS_B_INFECTION,118,Up,0.963135547209921,0.982183963471181
810,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.964552096353355,0.98241417221175
811,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.966560716574567,0.98324610502345
812,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.971215606860468,0.986379274683594
813,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.972031939779106,0.986379274683594
814,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,13,Up,0.976289884998869,0.988196206500576
815,WP_B_CELL_RECEPTOR_SIGNALING,87,Up,0.97657205177044,0.988196206500576
816,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.977415884247843,0.988196206500576
817,WP_MAPK_SIGNALING,157,Down,0.979263883760258,0.988852758999036
818,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,10,Down,0.981128240776774,0.989524203717407
819,WP_MALE_INFERTILITY,71,Down,0.988179445098189,0.995418854952388
820,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.990292556008578,0.996208465020478
821,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.993525960968419,0.996208465020478
822,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.993877630036663,0.996208465020478
823,WP_EICOSANOID_SYNTHESIS,13,Up,0.994859385591678,0.996208465020478
824,WP_DRAVET_SYNDROME,12,Down,0.995000939608332,0.996208465020478
825,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,14,Down,0.996432855728604,0.996432855728604
